Loading…

Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents

The novel 2,4-diaminoquinazolines 3–5 were easily prepared based on the reaction of polyhaloisophthalonitriles with guanidine carbonate. The anticancer and anti-HIV activities of 3–5 were evaluated in vitro. Compound 5a was the most potent derivative against the five tumor cell lines with an IC50 va...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2010-08, Vol.20 (15), p.4432-4435
Main Authors: Yan, Sheng-Jiao, Zheng, Han, Huang, Chao, Yan, Yu-Yun, Lin, Jun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583
cites cdi_FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583
container_end_page 4435
container_issue 15
container_start_page 4432
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Yan, Sheng-Jiao
Zheng, Han
Huang, Chao
Yan, Yu-Yun
Lin, Jun
description The novel 2,4-diaminoquinazolines 3–5 were easily prepared based on the reaction of polyhaloisophthalonitriles with guanidine carbonate. The anticancer and anti-HIV activities of 3–5 were evaluated in vitro. Compound 5a was the most potent derivative against the five tumor cell lines with an IC50 value lower than 2.5μg/mL, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of >59.6 and 66.6, respectively. Novel polyhalo 2,4-diaminoquinazolines 3a–3d were prepared by reacting polyhaloisophthalonitriles with guanidine carbonate under solvent-free conditions and in the absence of a catalyst with good yields (74–95%). A series of highly functionalized 2,4-diaminoquinazolines 4–5 were then synthesized based on 3a–3c. The anticancer activities of compounds 3–5 were evaluated in vitro against human cell lines such as Skov-3, HL-60, A431, A549, and HepG-2. Some of the compounds showed excellent cytotoxic activity and 5a was found to be the most potent derivative, with an IC50 value lower than 2.5μg/mL against the five tumor cell lines, making it more active than cisplatin. Representative compounds were also preliminarily evaluated as HIV-1 inhibitors in vitro, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of >59.6 and 66.6, respectively.
doi_str_mv 10.1016/j.bmcl.2010.06.056
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754539212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10008309</els_id><sourcerecordid>754539212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583</originalsourceid><addsrcrecordid>eNqFkEtr3DAURkVpaSbT_oEsgjelm3hy9RwLuimheUAgi6Sli4K4luWMBltOJU9h8usrZybJrgWBXud-3HsIOaKwoEDV6XpR97ZbMMgPoBYg1Rsyo0KJkguQb8kMtIKy0uLnATlMaQ1ABQjxnhwwkLqSHGbk1-02jCuXfCqGtlj5-1W3LdpNsKMfAnb-0TUFOxFl47H3Yfi98QEfh84HlwrMK4zeYrAu5mPzdC0vr34UeO_CmD6Qdy12yX3c73Py_fzb3dlleX1zcXX29bq0gi7HklOkDJeMWtlSXgNlTcOruuZtxZzSmKdwArBCZWuqldZ50vyvGEprUVZ8Tj7vch9i7tCl0fQ-Wdd1GNywSWYpheSaUfZ_knOd8-mUyXakjUNK0bXmIfoe49ZQMJN-szaTfjPpN6DM1NScHO_jN3XvmpeSZ98Z-LQHMFns2pjd-fTKcVBKaJq5LzvOZW1_vIsmWe-y58ZHZ0fTDP5fffwFOfCioA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733999018</pqid></control><display><type>article</type><title>Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents</title><source>ScienceDirect Journals</source><creator>Yan, Sheng-Jiao ; Zheng, Han ; Huang, Chao ; Yan, Yu-Yun ; Lin, Jun</creator><creatorcontrib>Yan, Sheng-Jiao ; Zheng, Han ; Huang, Chao ; Yan, Yu-Yun ; Lin, Jun</creatorcontrib><description>The novel 2,4-diaminoquinazolines 3–5 were easily prepared based on the reaction of polyhaloisophthalonitriles with guanidine carbonate. The anticancer and anti-HIV activities of 3–5 were evaluated in vitro. Compound 5a was the most potent derivative against the five tumor cell lines with an IC50 value lower than 2.5μg/mL, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively. Novel polyhalo 2,4-diaminoquinazolines 3a–3d were prepared by reacting polyhaloisophthalonitriles with guanidine carbonate under solvent-free conditions and in the absence of a catalyst with good yields (74–95%). A series of highly functionalized 2,4-diaminoquinazolines 4–5 were then synthesized based on 3a–3c. The anticancer activities of compounds 3–5 were evaluated in vitro against human cell lines such as Skov-3, HL-60, A431, A549, and HepG-2. Some of the compounds showed excellent cytotoxic activity and 5a was found to be the most potent derivative, with an IC50 value lower than 2.5μg/mL against the five tumor cell lines, making it more active than cisplatin. Representative compounds were also preliminarily evaluated as HIV-1 inhibitors in vitro, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.06.056</identifier><identifier>PMID: 20598530</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Anti-HIV activity ; Anti-HIV Agents - chemical synthesis ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Anticancer activity ; Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - therapeutic use ; Antiviral agents ; Biological and medical sciences ; Cell Line, Tumor ; Crystallography, X-Ray ; Drug Screening Assays, Antitumor ; General aspects ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Humans ; Medical sciences ; Molecular Conformation ; Neoplasms - drug therapy ; Pharmacology. Drug treatments ; Polyhalo 2,4-diaminoquinazoline ; Polyhaloisophthalonitrile ; Quinazolines - chemical synthesis ; Quinazolines - chemistry ; Quinazolines - therapeutic use ; Solvent-free synthesis ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-08, Vol.20 (15), p.4432-4435</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583</citedby><cites>FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23066491$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20598530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Sheng-Jiao</creatorcontrib><creatorcontrib>Zheng, Han</creatorcontrib><creatorcontrib>Huang, Chao</creatorcontrib><creatorcontrib>Yan, Yu-Yun</creatorcontrib><creatorcontrib>Lin, Jun</creatorcontrib><title>Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The novel 2,4-diaminoquinazolines 3–5 were easily prepared based on the reaction of polyhaloisophthalonitriles with guanidine carbonate. The anticancer and anti-HIV activities of 3–5 were evaluated in vitro. Compound 5a was the most potent derivative against the five tumor cell lines with an IC50 value lower than 2.5μg/mL, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively. Novel polyhalo 2,4-diaminoquinazolines 3a–3d were prepared by reacting polyhaloisophthalonitriles with guanidine carbonate under solvent-free conditions and in the absence of a catalyst with good yields (74–95%). A series of highly functionalized 2,4-diaminoquinazolines 4–5 were then synthesized based on 3a–3c. The anticancer activities of compounds 3–5 were evaluated in vitro against human cell lines such as Skov-3, HL-60, A431, A549, and HepG-2. Some of the compounds showed excellent cytotoxic activity and 5a was found to be the most potent derivative, with an IC50 value lower than 2.5μg/mL against the five tumor cell lines, making it more active than cisplatin. Representative compounds were also preliminarily evaluated as HIV-1 inhibitors in vitro, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively.</description><subject>Anti-HIV activity</subject><subject>Anti-HIV Agents - chemical synthesis</subject><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Anticancer activity</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Crystallography, X-Ray</subject><subject>Drug Screening Assays, Antitumor</subject><subject>General aspects</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Molecular Conformation</subject><subject>Neoplasms - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyhalo 2,4-diaminoquinazoline</subject><subject>Polyhaloisophthalonitrile</subject><subject>Quinazolines - chemical synthesis</subject><subject>Quinazolines - chemistry</subject><subject>Quinazolines - therapeutic use</subject><subject>Solvent-free synthesis</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkEtr3DAURkVpaSbT_oEsgjelm3hy9RwLuimheUAgi6Sli4K4luWMBltOJU9h8usrZybJrgWBXud-3HsIOaKwoEDV6XpR97ZbMMgPoBYg1Rsyo0KJkguQb8kMtIKy0uLnATlMaQ1ABQjxnhwwkLqSHGbk1-02jCuXfCqGtlj5-1W3LdpNsKMfAnb-0TUFOxFl47H3Yfi98QEfh84HlwrMK4zeYrAu5mPzdC0vr34UeO_CmD6Qdy12yX3c73Py_fzb3dlleX1zcXX29bq0gi7HklOkDJeMWtlSXgNlTcOruuZtxZzSmKdwArBCZWuqldZ50vyvGEprUVZ8Tj7vch9i7tCl0fQ-Wdd1GNywSWYpheSaUfZ_knOd8-mUyXakjUNK0bXmIfoe49ZQMJN-szaTfjPpN6DM1NScHO_jN3XvmpeSZ98Z-LQHMFns2pjd-fTKcVBKaJq5LzvOZW1_vIsmWe-y58ZHZ0fTDP5fffwFOfCioA</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Yan, Sheng-Jiao</creator><creator>Zheng, Han</creator><creator>Huang, Chao</creator><creator>Yan, Yu-Yun</creator><creator>Lin, Jun</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100801</creationdate><title>Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents</title><author>Yan, Sheng-Jiao ; Zheng, Han ; Huang, Chao ; Yan, Yu-Yun ; Lin, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-HIV activity</topic><topic>Anti-HIV Agents - chemical synthesis</topic><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Anticancer activity</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Crystallography, X-Ray</topic><topic>Drug Screening Assays, Antitumor</topic><topic>General aspects</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Molecular Conformation</topic><topic>Neoplasms - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyhalo 2,4-diaminoquinazoline</topic><topic>Polyhaloisophthalonitrile</topic><topic>Quinazolines - chemical synthesis</topic><topic>Quinazolines - chemistry</topic><topic>Quinazolines - therapeutic use</topic><topic>Solvent-free synthesis</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yan, Sheng-Jiao</creatorcontrib><creatorcontrib>Zheng, Han</creatorcontrib><creatorcontrib>Huang, Chao</creatorcontrib><creatorcontrib>Yan, Yu-Yun</creatorcontrib><creatorcontrib>Lin, Jun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Sheng-Jiao</au><au>Zheng, Han</au><au>Huang, Chao</au><au>Yan, Yu-Yun</au><au>Lin, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>20</volume><issue>15</issue><spage>4432</spage><epage>4435</epage><pages>4432-4435</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The novel 2,4-diaminoquinazolines 3–5 were easily prepared based on the reaction of polyhaloisophthalonitriles with guanidine carbonate. The anticancer and anti-HIV activities of 3–5 were evaluated in vitro. Compound 5a was the most potent derivative against the five tumor cell lines with an IC50 value lower than 2.5μg/mL, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively. Novel polyhalo 2,4-diaminoquinazolines 3a–3d were prepared by reacting polyhaloisophthalonitriles with guanidine carbonate under solvent-free conditions and in the absence of a catalyst with good yields (74–95%). A series of highly functionalized 2,4-diaminoquinazolines 4–5 were then synthesized based on 3a–3c. The anticancer activities of compounds 3–5 were evaluated in vitro against human cell lines such as Skov-3, HL-60, A431, A549, and HepG-2. Some of the compounds showed excellent cytotoxic activity and 5a was found to be the most potent derivative, with an IC50 value lower than 2.5μg/mL against the five tumor cell lines, making it more active than cisplatin. Representative compounds were also preliminarily evaluated as HIV-1 inhibitors in vitro, and 3c showed the most potent anti-HIV-1 activity with EC50 values of 0.6 and 1.6μg/mL, and TI values of &gt;59.6 and 66.6, respectively.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20598530</pmid><doi>10.1016/j.bmcl.2010.06.056</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (15), p.4432-4435
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_754539212
source ScienceDirect Journals
subjects Anti-HIV activity
Anti-HIV Agents - chemical synthesis
Anti-HIV Agents - chemistry
Anti-HIV Agents - therapeutic use
Antibiotics. Antiinfectious agents. Antiparasitic agents
Anticancer activity
Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - therapeutic use
Antiviral agents
Biological and medical sciences
Cell Line, Tumor
Crystallography, X-Ray
Drug Screening Assays, Antitumor
General aspects
Human immunodeficiency virus
Human immunodeficiency virus 1
Humans
Medical sciences
Molecular Conformation
Neoplasms - drug therapy
Pharmacology. Drug treatments
Polyhalo 2,4-diaminoquinazoline
Polyhaloisophthalonitrile
Quinazolines - chemical synthesis
Quinazolines - chemistry
Quinazolines - therapeutic use
Solvent-free synthesis
Structure-Activity Relationship
title Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A07%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20highly%20functionalized%202,4-diaminoquinazolines%20as%20anticancer%20and%20anti-HIV%20agents&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Yan,%20Sheng-Jiao&rft.date=2010-08-01&rft.volume=20&rft.issue=15&rft.spage=4432&rft.epage=4435&rft.pages=4432-4435&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.06.056&rft_dat=%3Cproquest_cross%3E754539212%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-31a12a721c5f13b012dd38bb3f82e69a960e40a8a6cb1969905638b62a5cca583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733999018&rft_id=info:pmid/20598530&rfr_iscdi=true